Bookmark

Add to MyYahoo RSS

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

7 hrs ago | Seeking Alpha

Retirement Strategy: The Buy The Dips Portfolio Continues To Surge

The portfolio has taken on a life of its own, and combined with my simple format of buying and selling prices, offers investors a unique strategy to explore.

Comment?

Related Topix: Personal Finance, Retirement, Financial Markets, Biotech, Medicine, Healthcare Industry, ExxonMobil Chemical, Exxon Mobil, Energy, Oil & Gas, Chemicals, Restaurant Management, Mcdonalds

Yesterday | Asbury Park Press

Anniversary: Sandra Franko & Philip Franko

They were married August 22, 1964 in St. Andrews Church, Avenel. Phil served in the US Navy from 1960-64, then worked for General Dynamics in Avenel for 32 years, retiring in 1996.

Comment?

Related Topix: East Brunswick, NJ, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Sat Aug 30, 2014

Learn Bonds

This Week's Top Bond Market Stories - August 30th Edition

LearnBonds: - Are bonds and commercial real estate the perfect mix? - Financial advisors are often quick to point out that investors absolutely need an allocation to stocks in their portfolios.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Financial Services, Franklin Resources, Investment Services, Mutual Funds, Personal Finance

Seeking Alpha

Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - August Update

When I began this little experiment, I had plenty of folks on both sides of the issue touting each direction.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Restaurant Management, Mcdonalds

Fri Aug 29, 2014

Federal Computer Week

President nominates Deyo to DHS management slot

The White House plans to nominate Russell C. Deyo to fill the Department of Homeland Security's undersecretary for management position left vacant when Raphael Borras departed this past winter.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

SchaeffersResearch.com

Buzz Stocks: Sprint Corporation, Baidu Inc (ADR), Google Inc, and Johnson & Johnson

U.S. stock futures are on track for a comeback this morning, with the major equity indexes looking to recover from Thursday's dip and build on their weekly gains.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Baidu, Startups, Micrus, Conor Medsystems

Learn Bonds

Take a Look at Johnson and Johnson - A True "Dividend Aristocrat"

If you're a trader, you might shy away from Johnson and Johnson at the moment. The giant healthcare products stock gave up six-plus points in 10 days this month after hitting its all-time high at $106.47 on July 7. What's more, at today's close of $102.11 the stock's dividend-adjusted PEG ratio is 1.64, a level where stocks are often poised for a ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Business Journal

J&J may be seeking buyer for Cordis, one of Boston Scientific's biggest rivals

While reports have surfaced saying that health care products giant Johnson & Johnson Inc. is seeking a buyer for its medical device business, the company is remaining tight lipped about the potential sale, which could affect local medical device maker Boston Scientific .

Comment?

Related Topix: Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Food, J and J Snack Foods, Biotech, Bridgewater, NJ

Reuters

Germany's Bayer to launch three new Xarelto trials

Germany's Bayer said it plans to launch three new studies to add more uses for its anti-clotting drug Xarelto, one of its top five new medicines.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Stroke, Health

Reuters

Deals of the day- Mergers and acquisitions

The sale could fetch between $1.5 billion and $2 billion, one of the people told the Journal.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

Reuters

Johnson & Johnson to seek buyer for medical device maker unit -WSJ

Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, OrthoClinical Diagnostics, Medical Equipment, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Thu Aug 28, 2014

Wall Street Journal

J&J Seeks Buyer for Cordis Unit

Johnson & Johnson plans to seek a buyer for a business that makes medical devices including stents and catheters, said people familiar with the matter, the latest effort by the health care giant to pare its wide-ranging portfolio.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

ComputerWorld

Paging Dr. Watson, IBM's medical adviser for the future

IBM continues to make the case for the nascent field of cognitive computing, showing off some Watson prototypes Thursday that could help speed scientific discovery in the medical field, by scanning large volumes of literature and data far more quickly then humans can, and suggesting possible leads.

Comment?

Related Topix: Science, Computer Science, Healthcare Law, Law, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

TheStreet.com

Why Johnson & Johnson (JNJ) Stock Is Declining Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Reuters

FDA says Johnson & Johnson recalls some jaw implants

Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Food and Drug Administration, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

CBC News

Jaw implants recalled

Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw, following more than a dozen cases of injury.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Motley Fool

Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences

Europe had already shown its willingness to support the use of daclatasvir, which will be sold under the brand name Daklinza, when it gave the OK for its compassionate use program last fall.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Healthcare Industry, Gilead Sciences

Heraldseries.co.uk

Service sector firms have helped boost Oxfordshire recovery

The county's economy grew by 3.5 per cent last year, compared with the national rate of 3.2 per cent, making it the second-best-performing area in the south east.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Outsourcing

TheStreet.com

Frustrating Boston Scientific Is Not What the Investor Ordered

The shares peaked in January at $14.08 and have grossly underperformed its peers ever since.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Aug 27, 2014

The Verona-Cedar Grove Times

J&J leads companies honing message to filter job applicants

New Brunswick-based Johnson & Johnson wants to hire workers. What it doesn't want is a flood of applicants taking a flier in a tough job market, a common occurrence in the aftermath of the recession.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Micrus

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••